A recent report from the European Commission’s Country Cancer Profiles has unveiled concerns about cancer care and patient outcomes in Ireland. While mortality rates have shown improvement, they remain alarmingly high relative to Western European standards.
Elevated Cost Burden
Health expenditure on cancer care is projected to soar by 80% in Ireland between 2023 and 2050, a figure that surpasses the EU average of 59%. This increase underscores the financial strain on the healthcare system and highlights the need for strategic planning to manage costs effectively.
Mortality Rates Remain High
Despite a significant decline in cancer mortality rates from 2011 to 2021, Ireland still ranks third highest in Western Europe, surpassing the EU average.
Shortages in Healthcare Personnel
The report identifies a critical shortage of GPs, radiologists, and radiation therapists, despite a higher ratio of physicians and nurses per new cancer case compared to the EU average. Addressing these gaps is essential for enhancing patient care and treatment outcomes.
Rising Vaping Rates Among Youth
A stark increase in vaping rates among Irish teens was a key finding, with rates jumping tenfold since 2015, from 1% to 10% by 2023. This trend poses a significant risk to public health and underscores the need for targeted interventions to curb youth tobacco use.
